Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 50 | 55 | +5 |
| Shares | 27.2M | 27.9M | +724.2K (+2.7%) |
| Value | $21.5M | $18.0M | −$3.49M (−16.3%) |
New holders (9)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 99,124 | $63.0K | 0.00% |
| Renaissance Technologies LLC | 33,800 | $21.0K | 0.00% |
| Global Assets Advisory, LLC | 18,250 | $14.0K | 0.01% |
| Citadel Advisors LLC | 20,801 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 19,349 | $12.0K | 0.00% |
| Cooper Financial Group | 13,903 | $9.00K | 0.00% |
| StoneX Group Inc. | 13,905 | $8.84K | 0.00% |
| HRT Financial LP | 12,977 | $8.00K | 0.00% |
| SlateStone Wealth, LLC | 10,000 | $6.00K | 0.00% |
Sold out (4)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| IPG Investment Advisors LLC | 57,385 | $45.0K |
| Schaper Benz & Wise Investment Counsel Inc | 14,493 | $11.0K |
| Venture Visionary Partners LLC | 4,813 | $3.80K |
| Global Wealth Management Investment Advisory, Inc. | 650 | $1.00K |